Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

Presentation TCT 2019

The BTK Interventional Toolbox: Wires and Crossing Devices

Presenter: Ehrin Armstrong

September 28, 2019

Presentation TCT 2019

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Presenter: Sahil Parikh

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

Optimal BTK POBA: Is There Science to the Art?

Presenter: Khusrow Niazi

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Presenter: Ehrin Armstrong

September 25, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

Advertisement

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

The BTK Interventional Toolbox: Wires and Crossing Devices

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

My Toughest BTK Case of the Year

Optimal BTK POBA: Is There Science to the Art?

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content